Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | -1.12% | -5.88% | -88.04% |
04-11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
04-10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
Sales 2024 * | 102M 8.15B | Sales 2025 * | 167K 13.34M | Capitalization | 120M 9.58B |
---|---|---|---|---|---|
Net income 2024 * | -105M -8.41B | Net income 2025 * | -84M -6.72B | EV / Sales 2024 * | 0.67 x |
Net cash position 2024 * | 51.6M 4.13B | Net cash position 2025 * | 168M 13.47B | EV / Sales 2025 * | -292 x |
P/E ratio 2024 * |
-1.15
x | P/E ratio 2025 * |
-1.49
x | Employees | 384 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.4% |
Latest transcript on Amylyx Pharmaceuticals, Inc.
1 day | -1.12% | ||
1 week | -5.88% | ||
Current month | -38.03% | ||
1 month | -35.77% | ||
3 months | -88.56% | ||
6 months | -88.97% | ||
Current year | -88.04% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 31/12/12 |
Josh Cohen
FOU | Founder | 33 | 31/12/12 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 31/12/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 31/12/14 |
Kari Firestone
BRD | Director/Board Member | - | 15/03/23 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 28/03/21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.09% | 237 M€ | +2.89% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.76 | -1.12% | 5,218,046 |
25/04/24 | 1.78 | -5.32% | 2,479,181 |
24/04/24 | 1.88 | -3.59% | 1,741,628 |
23/04/24 | 1.95 | -1.52% | 1,471,449 |
22/04/24 | 1.98 | +5.88% | 1,555,644 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.04% | 120M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- AMLX Stock